Citigroup Cuts Accendra Health (NYSE:ACH) Price Target to $4.50

Accendra Health (NYSE:ACH) had its price objective cut by Citigroup from $5.00 to $4.50 in a report published on Friday morning,Benzinga reports. They currently have a buy rating on the stock.

ACH has been the subject of several other reports. Weiss Ratings upgraded shares of Accendra Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, July 21st. UBS Group increased their target price on Accendra Health from $3.00 to $4.50 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Robert W. Baird raised their target price on Accendra Health from $5.00 to $6.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. Finally, Zacks Research raised shares of Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $5.00.

Accendra Health Trading Down 0.3%

Shares of ACH stock opened at $3.13 on Friday. The company has a market cap of $239.70 million, a price-to-earnings ratio of -0.22, a P/E/G ratio of 4.84 and a beta of 1.58. The stock has a 50 day simple moving average of $3.12. Accendra Health has a fifty-two week low of $1.84 and a fifty-two week high of $7.99.

Accendra Health (NYSE:ACH) last issued its quarterly earnings data on Monday, May 11th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.02. Accendra Health had a negative net margin of 39.84% and a negative return on equity of 13.18%. The business had revenue of $627.78 million during the quarter. On average, research analysts forecast that Accendra Health will post 0.31 EPS for the current fiscal year.

Institutional Investors Weigh In On Accendra Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Paradigm Capital Management Inc. NY bought a new stake in Accendra Health in the first quarter worth about $4,073,000. Strs Ohio purchased a new position in Accendra Health in the first quarter worth $413,000. Abel Hall LLC acquired a new position in shares of Accendra Health during the first quarter worth $44,000. Renaissance Technologies LLC acquired a new position in shares of Accendra Health during the first quarter worth $725,000. Finally, Sei Investments Co. purchased a new stake in shares of Accendra Health during the 1st quarter valued at $123,000.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.